The ovarian cancer market in the Asia-Pacific region will maintain steady growth in the next 6 years

Release date: 2015-04-13

According to a research report released by globally renowned market research firm GBI Research, in the next 6 years (2014-2020), the Asia Pacific (APAC) ovarian cancer (OC) treatment market will grow steadily with a CAGR of 5.1% to 2020. The year reached $417.6 million. The market had a market capitalization of $294.3 million in 2013.

Japan has the largest market share in the ovarian cancer treatment market in the Asia-Pacific region, with 62% in 2013; followed by China with a market share of 16.5%; the rest are Australia, India and other countries. Overall, the ovarian cancer treatment market in the Asia-Pacific region will continue to grow steadily during the forecast period, mainly due to the growth of the patient population in the region, especially India and China.

The report points out that two key unmet clinical needs for ovarian cancer treatment will also spur steady growth in the Asia Pacific market during the forecast period: one is the clinical need for effective treatments for platinum-resistant ovarian cancer patients; After first-line and second-line treatment, patients need an effective maintenance therapy to prolong disease progression-free survival (PFS), a requirement that is concentrated in the platinum-sensitive ovarian cancer population. New drugs that have been successful in the clinic will further stimulate drug development in the field of ovarian cancer.

The report also pointed out that the current ovarian cancer drug pipeline has a stable number of drug candidates from early to late stages, and it is expected that new drugs will continue to be marketed throughout the forecast period. However, although the late pipeline is already very crowded, there is no significant improvement in overall survival (OS), and most of the late-line drugs offer very little clinical benefit, compared to current standard care. Mild to moderate improvement in progressive survival (PFS). The most promising experimental drug olaparib (AstraZeneca R&D, approved in Europe and the US) and Trebananib (Anjin R&D) are expected to be available in the Asia Pacific region during the forecast period, however these drugs are not expected to achieve high market penetration. Mainly due to limited efficacy and expected high prices.

On the other hand, the proliferation of generic drugs in the Asia Pacific market will limit the prescription capacity of these prospective new drugs in four major Asia Pacific countries. As a result, the entire ovarian cancer treatment market in the Asia-Pacific region will not change dramatically until 2020, but will only grow steadily. It is worth mentioning that this growth is not expected to be stimulated by the launch of new drugs, but by inflation and the increase in the incidence of ovarian cancer.

However, despite the current unsatisfactory clinical performance of the pipeline drugs in the late stage, there are indications that the pharmaceutical industry continues to maintain a strong interest in the ovarian cancer market, as evidenced by the large number of drug candidates in the early pipeline, especially in the preclinical phase. At the same time, a wide range of new molecular targets are distributed among these drug candidates, including growth factors, serine/threonine protein kinases, tumor-associated antigens, and the like. This indicates that the industry has a continuing interest in introducing more targeted therapies into the treatment of ovarian cancer. Compared to other fields of oncology, the development of targeted therapies in the field of ovarian cancer treatment has lagged behind.

Source: Bio Valley

Linux Intercom System

The IP intercom system is an intercom system connected by a network cable and POE Switch connects the whole system for stable intercom and monitoring.

The intercom system we developed was Linux intercom system, which can support intercom, monitoring and unlocking functions. They are based on Linux system, adopt TCP/IP networking architecture, and support multi-way unlocking and elevator linkage. Our equipment supports the connection of 9999pcs apartments at most, which can meet the needs of most projects. At the same time, they also support connection to the central management machine, which is convenient for the management of properties and communities.

There are functions of Video Door Phone:

1. Support face recognition, which can be unlocked by dynamic face information;

2. Support card opening, which can be unlocked by IC/ID/NFC cards;

3. Support monitor, which can be monitoring by Indoor Monitor;

4. Support video intercom, when someone coming and users can see who is coming;

5. Support intercom, indoor units can call and intercom with each other;

6. Support customization language, which can be made on the intercom system

7. Support elevator linkage on the indoor monitor

ip intercom system

Our intercom systems have various designs to meet the needs of different customers. We have 4.3-inch and 10.1-inch screens with physical buttons, touch buttons and sensor buttons for customers to choose. Refer to the following pictures.

intercom system

They all use color high-definition display, aluminum alloy shell and luminous solid buttons. They can be used in multi-apartment systems, can be used in apartments, buildings, hotels, etc.

Our factory is located in Zhuhai, China. We have been focusing on independent research and development of intercom systems for 11 years. We can provide you with professional products and services, as well as complete intercom solutions according to your requirements. If you want to know more, please contact us and we can send a catalogue for your reference.

FAQ

Q: What is your service ?

a. we can offer OEM&ODM services

b. All software free provide , and technical support after-service

c. Online installation guide services.

Q: Whats the MOQ?

To ensure the best logistic cost, we suggest 100pcs(one carton).However, we are open to take orders with small qty.Welcome to sample order, contact with us.

Q: What payment terms are available?

T/T, Paypal, Western Union, credit card.

Q: How long is your production lead time?

Sample Order-Within 1-5 working days.

Bulk Order - 15-20 days for neutral items, 7 days if the items we have stock

Q: What's Your Products Warranty?

We Offer 12 Months Warranty after shipment sent.

Linux Intercom System,Intercom System,Intercom System For Home,Gate Intercom Systems

Zhuhai Mingke Electronics Technology Co., Ltd , https://www.zhmkdz-electronics.com